Latest Period
n/a
Security Snapshot
UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value (UPC) Institutional Ownership
CUSIP: G9442G104
13F Institutional Holders and Ownership History from Q1 2021 to Q3 2023
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Ordinary Shares, $0.01875 par value
- Symbol
- UPC on Nasdaq
- Shares outstanding
- 7,902,293
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- UPC - UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value is tracked under CUSIP G9442G104.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 4 to 0 between Q2 2023 and Q3 2023.
- Reported value moved from $33,654 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
G9442G104
Latest holder period
n/a
13F holders
13D/G owners
2
CIK / CUSIP context first
UPC full holder history
Universe Pharmaceuticals INC SEC filings
Universe Pharmaceuticals INC company facts
Universe Pharmaceuticals INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G9442G104:
Significant Owners of UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value (UPC) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9.9% | $254,516 | 727,190 | SABBY MANAGEMENT, LLC | 31 Dec 2024 | |||
| Anson Funds Management LP | 1% | -89% | 234,374 | -70% | Anson Funds Management LP | 31 Mar 2025 |
Institutional Holders of UNIVERSE PHARMACEUTICALS, INC. - Ordinary Shares, $0.01875 par value (UPC) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q3 | 0 | $0 | -$33,654 | 0 | |
| 2023 Q2 | 98,532 | $33,654 | +$9,582 | $0.36 | 4 |
| 2023 Q1 | 71,549 | $40,000 | -$537 | $0.56 | 2 |
| 2022 Q4 | 65,749 | $93,670 | +$29,870 | $1.45 | 3 |
| 2022 Q3 | 44,223 | $24,000 | -$154,239 | $0.55 | 3 |
| 2022 Q2 | 289,650 | $181,000 | -$513,116 | $0.62 | 4 |
| 2022 Q1 | 1,107,394 | $1,401,000 | -$128,863 | $1.27 | 4 |
| 2021 Q4 | 1,193,142 | $1,949,000 | +$1,330,096 | $1.61 | 5 |
| 2021 Q3 | 341,302 | $844,000 | +$742,584 | $2.48 | 5 |
| 2021 Q2 | 40,919 | $151,000 | -$155,255 | $3.48 | 2 |
| 2021 Q1 | 82,906 | $332,000 | +$332,000 | $4.01 | 4 |